1. Home
  2. LXRX vs CWCO Comparison

LXRX vs CWCO Comparison

Compare LXRX & CWCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • CWCO
  • Stock Information
  • Founded
  • LXRX 1995
  • CWCO 1973
  • Country
  • LXRX United States
  • CWCO Cayman Islands
  • Employees
  • LXRX N/A
  • CWCO N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • CWCO Water Supply
  • Sector
  • LXRX Health Care
  • CWCO Utilities
  • Exchange
  • LXRX Nasdaq
  • CWCO Nasdaq
  • Market Cap
  • LXRX 552.4M
  • CWCO 577.2M
  • IPO Year
  • LXRX 2000
  • CWCO N/A
  • Fundamental
  • Price
  • LXRX $1.37
  • CWCO $35.40
  • Analyst Decision
  • LXRX Buy
  • CWCO Strong Buy
  • Analyst Count
  • LXRX 5
  • CWCO 1
  • Target Price
  • LXRX $3.23
  • CWCO $40.00
  • AVG Volume (30 Days)
  • LXRX 2.6M
  • CWCO 90.6K
  • Earning Date
  • LXRX 11-04-2025
  • CWCO 11-13-2025
  • Dividend Yield
  • LXRX N/A
  • CWCO 1.58%
  • EPS Growth
  • LXRX N/A
  • CWCO N/A
  • EPS
  • LXRX N/A
  • CWCO 0.99
  • Revenue
  • LXRX $58,432,000.00
  • CWCO $129,104,549.00
  • Revenue This Year
  • LXRX $66.55
  • CWCO $1.99
  • Revenue Next Year
  • LXRX N/A
  • CWCO $57.75
  • P/E Ratio
  • LXRX N/A
  • CWCO $35.85
  • Revenue Growth
  • LXRX 1504.83
  • CWCO N/A
  • 52 Week Low
  • LXRX $0.28
  • CWCO $22.69
  • 52 Week High
  • LXRX $2.08
  • CWCO $36.88
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 48.43
  • CWCO 55.69
  • Support Level
  • LXRX $1.36
  • CWCO $35.65
  • Resistance Level
  • LXRX $1.48
  • CWCO $36.88
  • Average True Range (ATR)
  • LXRX 0.10
  • CWCO 0.76
  • MACD
  • LXRX -0.02
  • CWCO -0.05
  • Stochastic Oscillator
  • LXRX 3.33
  • CWCO 58.45

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About CWCO Consolidated Water Co. Ltd.

Consolidated Water Co Ltd is a water utility company. It develops and operates seawater desalination plants and water distribution systems. The company's business segments are; The retail segment operates the water utility for the Seven Mile Beach and West Bay areas of Grand Cayman Island, The bulk segment supplies potable water to government utilities in Grand Cayman and The Bahamas under long-term contracts, The services segment designs, constructs and sells water infrastructure and provides management and operating services to third parties. The manufacturing segment manufactures and services a wide range of custom and specialized water-related products applicable to commercial, municipal, and industrial water production, supply, and treatment, and the corporate segment.

Share on Social Networks: